Microalgal docosahexaenoic acid decreases plasma triacylglycerol in normolipidaemic vegetarians: A randomised trial

British Journal of Nutrition

Volumn 95, Issue 4, 2006, Pages 779-786

  Geppert, Julia ^a   Kraft, Veronika ^a   Demmelmair, Hans ^a   Koletzko, Berthold ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Docosahexaenoic acid; Microalgae oil; Plasma lipids; Triacylglycerol

Indexed keywords

DOCOSAHEXAENOIC ACID; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; ICOSAPENTAENOIC ACID; LIPID; LONG CHAIN FATTY ACID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; OLIVE OIL; OMEGA 3 FATTY ACID; PLACEBO; POLYUNSATURATED FATTY ACID; TRIACYLGLYCEROL;

ADULT; ALGA; ARTICLE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DIET SUPPLEMENTATION; DIETARY INTAKE; DOUBLE BLIND PROCEDURE; DRUG ACTIVITY; DRUG SAFETY; DRUG TOLERABILITY; ERUCTATION; FAT INTAKE; FLATULENCE; GASTROINTESTINAL SYMPTOM; HUMAN; HUMAN EXPERIMENT; ISCHEMIC HEART DISEASE; LIPID BLOOD LEVEL; MALE; NORMAL HUMAN; PARALLEL DESIGN; RANDOMIZED CONTROLLED TRIAL; SKIN MANIFESTATION; STOMACH PAIN; TRIACYLGLYCEROL BLOOD LEVEL; ULKENIA; VEGETARIAN;

ADOLESCENT; ADULT; ALPHA-TOCOPHEROL; DIET, VEGETARIAN; DIETARY SUPPLEMENTS; DOCOSAHEXAENOIC ACIDS; DOUBLE-BLIND METHOD; ERYTHROCYTES; FATTY ACIDS; FEMALE; HUMANS; LIPIDS; LIPOPROTEINS; MALE; PATIENT COMPLIANCE; TRIGLYCERIDES;

ALGAE; ULKENIA; ULKENIA SP.;

EID: 33646456779     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1079/BJN20051720     Document Type: Article

References (42)

1. Abbey M, Clifton P, Kestin M, Belling B & Nestel P (1990) Effect of fish oil on lipoproteins, lecithin:cholesterol acyltransferase, and lipid transfer protein activity in humans. Arteriosclerosis 10, 85-94.
2. Agren JJ, Hanninen O, Julkunen A, Fogelholm L, Vidgren H, Schwab U, Pynnonen O & Uusitupa M (1996) Fish diet, fish oil and docosahexaenoic acid rich oil lower fasting and postprandial plasma lipid levels. Eur J Clin Nutr 50, 765-771.
3. Austin MA, Hokanson JE & Edwards KL (1998) Hypertriglyceridemia as a cardiovascular risk factor. Am J Cardiol 81, 7B-12B.
4. Bonaa KH, Bjerve KS, Straume B, Gram IT & Thelle D (1990) Effect of eicosapentaenoic and docosahexaenoic acids on blood pressure in hypertension. A population-based intervention trial from the Tromso study. N Engl J Med 322, 795-801.
5. Buckley R, Shewring B, Turner R, Yaqoob P & Minihane AM (2004) Circulating triacylglycerol and apoE levels in response to EPA and docosahexaenoic acid supplementation in adult human subjects. Br J Nutr 92, 477-483.
6. Conquer JA & Holub BJ (1996) Supplementation with an algae source of docosahexaenoic acid increases (n-3) fatty acid status and alters selected risk factors for heart disease in vegetarian subjects. J Nutr 126, 3032-3039.
7. Conquer JA & Holub BJ (1998) Effect of supplementation with different doses of DHA on the levels of circulating DHA as non-esterified fatty acid in subjects of Asian Indian background. J Lipid Res 39, 286-292.
8. Davidson MH, Maki KC, Kalkowski J, Schaefer EJ, Torri SA & Drennan KB (1997) Effects of docosahexaenoic acid on serum lipoproteins in patients with combined hyperlipidemia: a randomized, double-blind, placebo-controlled trial. J Am Coll Nutr 16, 236-243.
9. Fisher WR, Zech LA & Stacpoole PW (1998) Apolipoprotein B metabolism in hypertriglyceridemic diabetic patients administered either a fish oil- or vegetable oil-enriched diet. J Lipid Res 39, 388-401.
10. Friedewald WT, Levy RI & Fredrickson DS (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18, 499-502.
11. Gaziano JM, Hennekens CH, O'Donnell CJ, Breslow JL & Buring JE (1997) Fasting triglycerides, high-density lipoprotein, and risk of myocardial infarction. Circulation 96, 2520-2525.
12. Geppert J, Kraft V, Demmelmair H & Koletzko B (2005) Docosahexa enoic acid supplementation in vegetarians effectively increases omega-3 index: a randomized trial. Lipids 40, 870-814.
13. Griffin BA (2001) The effect of n-3 fatty acids on low density lipoprotein subfractions. Lipids 36, S91-S97.
14. Grimsgaard S, Bonaa KH, Hansen JB & Myhre ES (1998) Effects of highly purified eicosapentaenoic acid and docosahexaenoic acid on hemodynamics in humans. Am J Clin Nutr 68, 52-59.
15. Grimsgaard S, Bonaa KH, Hansen JB & Nordoy A (1997) Highly purified eicosapentaenoic acid and docosahexaenoic acid in humans have similar triacylglycerol-lowering effects but divergent effects on serum fatty acids. Am J Clin Nutr 66, 649-659.
16. Grover SA, Coupal L & Hu XP (1995) Identifying adults at increased risk of coronary disease. How well do the current cholesterol guidelines work? JAMA 274, 801-806.
17. Grover SA, Palmer CS & Coupal L (1994) Serum lipid screening to identify high-risk individuals for coronary death. The results of the Lipid Research Clinics prevalence cohort. Arch Intern Med 154, 679-684.
18. Harris WS (1997) N-3 fatty acids and serum lipoproteins: human studies. Am J Clin Nutr 65, 1645S-1654S.
19. Hess D, Keller HE, Oberlin B, Bonfanti R & Schuep W (1991) Simultaneous determination of retinol, tocopherols, carotenes and lycopene in plasma by means of high-performance liquid chromatography on reversed phase. Int J Vit Nutr Res 61, 232-238.
20. Hodis HN (1999) Triglyceride-rich lipoprotein remnant particles and risk of atherosclerosis. Circulation 99, 2852-2854.
21. Hokanson JE & Austin MA (1996) Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population-based prospective studies. J Cardiovasc Risk 3, 213-219.
22. Illingworth DR, Harris WS & Connor WE (1984) Inhibition of low density lipoprotein synthesis by dietary omega-3 fatty acids in humans. Arteriosclerosis 4, 270-275.
23. Inagaki M & Harris WS (1990) Changes in lipoprotein composition in hypertriglyceridemic patients taking cholesterol-free fish oil supplements. Atherosclerosis 82, 237-246.
24. Kinosian B, Glick H & Garland G (1994) Cholesterol and coronary heart disease: predicting risks by levels and ratios. Ann Intern Med 121, 641-647.
25. Kinosian B, Glick H, Preiss L & Puder KL (1995) Cholesterol and coronary heart disease: predicting risks in men by changes in levels and ratios. J Invest Med 43, 443-450.
26. Knapp HR & FitzGerald GA (1989) The antihypertensive effects of fish oil. A controlled study of polyunsaturated fatty acid supplements in essential hypertension. N Engl J Med 320, 1037-1043.
27. Leigh-Firbank EC, Minihane AM, Leake DS, Wright JW, Murphy MC, Griffin BA & Williams CM (2002) Eicosapentaenoic acid and docosahexaenoic acid from fish oils: differential associations with lipid responses. Br J Nutr 87, 435-445.
28. Lindsey S, Pronczuk A & Hayes KC (1992) Low density lipoprotein from humans supplemented with n-3 fatty acids depresses both LDL receptor activity and LDLr mRNA abundance in HepG2 cells. J Lipid Res 33, 647-658.
29. Lu G, Windsor SL & Harris WS (1999) Omega-3 fatty acids alter lipoprotein subfraction distributions and the in vitro conversion of very low density lipoproteins to low density lipoproteins. J Nutr Biochem 10, 151-158.
30. Lungershausen YK, Abbey M, Nestel PJ & Howe PRC (1994) Reduction of blood pressure and plasma triglycerides by omega-3 3 fatty acids in treated hypertensives. J Hypertens 12, 1041-1045.
31. Mori TA, Bao DQ, Burke V, Puddey IB & Beilin LJ (1999) Docosahexaenoic acid but not eicosapentaenoic acid lowers ambulatory blood pressure and heart rate in humans. Hypertension 34, 253-260.
32. Mori TA, Burke V, Puddey IB, Watts GF, O'Neal DN, Best JD & Beilin LJ (2000) Purified eicosapentaenoic and docosahexaenoic acids have differential effects on serum lipids and lipoproteins, LDL particle size, glucose, and insulin in mildly hyperlipidemic men. Am J Clin Nutr 71, 1085-1094.
33. Nelson GJ, Schmidt PC, Bartolini GL, Kelley DS & Kyle D (1997) The effect of dietary docosahexaenoic acid on plasma lipoproteins and tissue fatty acid composition in humans. Lipids 32, 1137-1146.
34. Nestel PJ (2000) Fish oil and cardiovascular disease: lipids and arterial function. Am J Clin Nutr 71, 228-231.
35. Nestel P, Shige H, Pomeroy M, Cehun M, Abbey M & Raederstorff D (2002) The n-3 fatty acids eicosapentaenoic acid and docosahexaenoic acid increase systemic arterial compliance in humans. Am J Clin Nutr 76, 326-330.
36. Rambjor GS, Walen AI, Windsor SL & Harris WS (1996) Eicosapentaenoic acid is primarily responsible for hypotriglyceridemic effect of fish oil in humans. Lipids 31, S45-S49.
37. Sanders TAB & Hinds A (1992) The influence of a fish oil high in docosahexaenoic acid on plasma lipoprotein and vitamin E concentrations and haemostatic function in healthy male volunteers. Br J Nutr 68, 163-173.
38. Schectman G, Boerboom LE, Hannah J, Howard BV, Mueller RA & Kissebah AH (1996) Dietary fish oil decreases low-density-lipoprotein clearance in nonhuman primates. Am J Clin Nutr 64, 215-221.
39. Stark KD & Holub BJ (2004) Differential eicosapentaenoic acid elevations and altered cardiovascular disease risk factor responses after supplementation with docosahexaenoic acid in postmenopausal women receiving and not receiving hormone replacement therapy. Am J Clin Nutr 79, 765-773.
40. Surette ME, Whelan J, Lu GP, Broughton KS & Kinsella JE (1992) Dependence on dietary cholesterol for n-3 polyunsaturated fatty acid-induced changes in plasma cholesterol in the Syrian hamster. J Lipid Res 33, 263-271.
41. Theobald HE, Chowienczyk PJ, Whittall R, Humphries SE & Sanders TAB (2004) LDL cholesterol-raising effect of low-dose docosahexaenoic acid in middle-aged men and women. Am J Clin Nutr 79, 558-563.
42. Toft I, Bonaa KH, Ingebretsen OC, Nordoy A & Jenssen T (1995) Effects of n-3 polyunsaturated fatty acids on glucose homeostasis and blood pressure in essential hypertension: a randomized, controlled trial. Ann Intern Med 123, 911-918.